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Aims Vascular disease states are associated with endothelial dysfunction and increased production of reactive oxygen
species derived from NADPH oxidases. However, it remains unclear whether a primary increase in superoxide pro-
duction speciﬁcally in the endothelium alters the initiation or progression of atherosclerosis.
Methods
and results
Mice overexpressing Nox2 speciﬁcally in the endothelium (Nox2-Tg) were crossed with ApoE
2/2 mice to produce
Nox2-Tg ApoE
2/2 mice and ApoE
2/2 littermates. Endothelial overexpression of Nox2 in ApoE
2/2 mice did not
alter blood pressure, but signiﬁcantly increased vascular superoxide production compared with ApoE
2/2 littermates,
measured using both lucigenin chemiluminescence and 2-hydroxyethidium production (ApoE
2/2, 19.9+6.3 vs.
Nox2-Tg ApoE
2/2, 47.0+7.0 nmol 2-hydroxyethidium/aorta, P , 0.05). Increased endothelial superoxide produc-
tion increased endothelial levels of vascular cell adhesion protein 1 and enhanced macrophage recruitment in early
lesions in the aortic roots of 9-week-old mice, indicating increased atherosclerotic plaque initiation. However, endo-
thelial-speciﬁc Nox2 overexpression did not alter native or angiotensin II-driven atherosclerosis in either the aortic
root or the descending aorta.
Conclusion Endothelial-targeted Nox2 overexpression in ApoE
2/2 mice is sufﬁcient to increase vascular superoxide production
and increase macrophage recruitment possible via activation of endothelial cells. However, this initial increase in
macrophage recruitment did not alter the progression of atherosclerosis. These results indicate that Nox-mediated
reactive oxygen species signalling has important cell-speciﬁc and distinct temporal roles in the initiation and progres-
sion of atherosclerosis.
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1. Introduction
Increased production of reactive oxygen species (ROS) in the vascular
wall is a hallmark of vascular disease states including atherosclerosis,
diabetes, and hypertension.
1 Excessive generation of ROS, particularly
superoxide, is thought to be an important mediator of atherosclerotic
initiation by causing increased oxidative stress, recruitment of
inﬂammatory cells, and endothelial dysfunction. However, very few
studies to date have assessed whether increasing ROS production
speciﬁcally in the endothelial cell layer is enough to accelerate the ini-
tiation and progression of atherosclerosis.
The NADPH oxidases are major sources of ROS in the vasculature,
generating superoxide from molecular oxygen using NADPH as the
electron donor. NADPH oxidases are multi-subunit, membrane-bound
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bound Nox catalytic subunit.
2 Tissue-speciﬁc Nox expression is
observed in the vasculature, with Nox2 and Nox4 being expressed
in endothelial cells,
3,4 whereas in vascular smooth muscle cells
(VSMCs) Nox1 and Nox4 predominate.
5,6 NADPH oxidase-derived
ROS have important roles in vascular disease pathogenesis. Both
Nox2 and Nox4 have been shown to be localized within the
plaque of diseased human coronary arteries.
7 However, only Nox2
has been shown to be up-regulated in response to atherosclerosis.
8,9
Previous studies investigating the role of NADPH oxidase in the de-
velopment of atherosclerosis have produced mixed results with
initial studies of global Nox2
10 and p47Phox knockout mice
11
showing no difference in atherosclerosis in the aortic sinus. More
recent studies have shown that global knockout of p47phox results
in a moderate decrease in aortic atherosclerosis in both chow and
high-fat fed animals,
12 and that global Nox2 deletion results in a signiﬁ-
cant decrease in aortic atherosclerotic burden.
9 However, while all
studies to date have investigated whether a decrease in superoxide
production altered the progression of atherosclerosis, very few
have assessed if increasing superoxide production speciﬁcally in the
endothelial cell layer alters the progression of atherosclerosis.
Thus far, very few studies have addressed the relative importance
of the cellular source(s) of ROS in the pathology of vascular diseases.
Although total vascular superoxide production is associated with vas-
cular disease risk factors and endothelial dysfunction,
13,14 it is possible
that superoxide production in speciﬁc cell types might have particular
importance. For example, the up-regulation of endothelial Nox2
expression and NADPH oxidase-derived ROS reported in ApoE
2/2
mice might more likely favour endothelial dysfunction and
atherosclerosis.
9 Although some studies have already addressed the
potential role of NADPH oxidase-dependent ROS production in
VSMCs and inﬂammatory cells, it remains unclear whether increasing
superoxideproductionspeciﬁcallyintheendotheliumaloneissufﬁcient
to alter the initiation and progression of atherosclerosis. To address
this question, we determined how endothelial cell-speciﬁc Nox2
overexpression would alter total vascular superoxide production in
ApoE
2/2 mice, and the effects of endothelial cell-speciﬁc Nox2
overexpression on the initiation and progression of atherosclerosis.
2. Methods
2.1 Animals
Endothelial-targeted Nox2 transgenic mice (Nox2-Tg), overexpressing
human Nox2 under the control of the Tie2 promoter/enhancer,
15 were
crossed with ApoE
2/2 mice (Jackson laboratories, USA) to generate
matched litters of Nox2-Tg ApoE
2/2 and ApoE
2/2 mice. Animals were
housed in individually ventilated cages with 12 h light/dark cycle and con-
trolled temperature (20–228C). Standard chow (B&K Ltd, UK) and water
were available ab libitum. Genotyping of experimental mice was per-
formed by standard PCR techniques to conﬁrm the presence or
absence of the ApoE gene and human Nox2 transgene. Tissue for
primary cell cultures and assays was isolated from mice after culling
with an overdose of anaesthetic (isoﬂurane .20%) and conﬁrmation of
death by either cervical dislocation or exsanguination. All animal proce-
dures were approved and carried out in accordance with the University
of Oxford Ethics Committee and the UK Home Ofﬁce Animals (Scientiﬁc
Procedures) Act 1986. All procedures conformed with the Directive
2010/63/EU of the European Parliament.
2.2 Quantitative real-time RT–PCR
Primary cells and whole thoracic aortas were obtained from 16-week-old
Nox2-Tg ApoE
2/2 mice and their ApoE
2/2 littermates. Primary endo-
thelial cells were isolated from lungs by immunoselection with CD31 anti-
body (BD Biosciences, UK)-coated magnetic Dynabeads (Invitrogen, UK)
as described previously.
15 VSMCs were obtained from the thoracic aorta
by established culture techniques.
16 Resident peritoneal macrophages
were obtained after peritoneal lavage and plastic selection. Total RNA
was obtained by Trizol extraction. Reverse transcription was carried
out using the QuantiTect reverse transcription kit (Qiagen, UK) on
1 mg total cell RNA. Quantitative real-time RT–PCR was performed
with an iCycler IQ real-time detection system (BioRad Laboratories,
USA) using primers and probes from the TaqMan Gene Expression
Assay system (Applied Biosystems, UK).
2.3 Western blotting
Western blotting was carried out on lung homogenates (15 mg protein)
using standard techniques and anti-Nox2, (BD Transduction Laboratories,
USA) and GAPDH (Chemicon, USA) antibodies.
2.4 Quantiﬁcation of superoxide production
Superoxide production from thoracic aortas of 24-week-old mice was
measured by quantifying the accumulation of 2-hydroxyethidium by
HPLC as previously described.
17 Brieﬂy, aortas were incubated at
378C in Krebs-HEPES buffer containing dihydroethidium (25 mM;
DHE) and NADPH (300 mmol/L) for 30 min. Separation of DHE,
2-hydroxyethidium, and ethidium was performed using a gradient HPLC
system (Jasco, UK) with an ODS3 reverse phase column (250, 4.5 mm;
Hichrom, UK), and quantiﬁed using a ﬂuorescence detector set at
510 nm (excitation) and 595 nm (emission).
Superoxide production in the aortic root of 9-week-old mice was
assessed using DHE in frozen aortic root sections (10 mm) incubated
with DHE (2 mmol/L; Molecular Probes) at 378C for 20 min. 2-
hydroxyethidum production was assessed on a Zeiss scanning confocal
microscope with a ×63 oil immersion objective. Staining was quantiﬁed
in images throughout the aortic root and speciﬁcally in the endothelium
by quantifying ﬂuorescence on the luminal side of the internal elastic
lamina using Image Pro Plus (MediaCybernetics, USA).
Superoxide generation was also measured by lucigenin-enhanced
chemiluminescence, as previously described.
14,18 Chemiluminescence of
freshly harvested intact aortas (9–18 weeks) was measured in a FB12
luminometer (Berthold Detection Systems, Germany) at 378C under
basal conditions and after addition of NADPH (300 mmol/L), followed
by the NADPH oxidase ﬂavoprotein inhibitor diphenyleneiodonium
(DPI; 10 mmol/L).
2.5 Blood pressure and pulse measurements
in conscious mice
The heart rate and the systolic blood pressure were measured using an
automated computerized tail-cuff system in conscious mice following
ﬁve consecutive training periods (Visitech BP2000, Visitech Systems,
Inc., USA). All recordings were performed between 0800 and 1200 h,
on 9- and 20–24-week-old mice. To ensure accuracy, 20 preliminary
recordings were taken followed by 15 actual recordings for each animal.
The mean of these 15 recordings was used for blood pressure and
heart rate analysis.
2.6 Lipid and lipoprotein analysis
Biochemical analyses of plasma lipids were performed on heparinized
blood plasma using an ABX Pentra Clinical Chemistry bench-top analyser
(Horiba ABX, France). Oxidized LDL (OxLDL) was measured in hepari-
nized blood plasma using a murine OxLDL sandwich ELISA (USCN,
China).
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atherosclerotic aortic root sections
Lesion size was assessed in parafﬁn-embedded aortic root sections stained
with Masson-Goldner trichrome (Merck, Germany). The average lesion
size was calculated from three sections taken at 100 mm intervals starting
from the section showing all three aortic cusps. The inﬁltration of macro-
phages into aortic lesions was analysed using anti-Mac-3 (BD Pharmingen,
UK) immunostaining. Plaque smooth muscle cell content was assessed
using a-smooth muscle actin (Sigma-Aldrich, UK) immunostaining. Apop-
tosis was assessed using the ApopTag Peroxidase In Situ Apoptosis Detec-
tion kit (Millipore, USA). The collagen content of atherosclerosic plaques
was analysed using Masson-Goldner stained sections (Merck, Germany).
Vascular cell adhesion molecule 1 (VCAM-1) and CD68 expression in
aortic roots was assessed in acetone-ﬁxed frozen sections using
anti-VCAM-1 (Southern Biotech, UK) and anti-CD68 (AbD Serotec, UK).
Aortic lipid deposition was assessed in ﬁxed aortas stained with Oil red
O. The lesion area, and Mac-3, CD68, and VCAM-1 positive areas were
quantiﬁed from digitized microscopic images using Image-Pro Plus.
2.8 In vivo angiotensin II infusion
ApoE
2/2 and Nox2-Tg ApoE
2/2 mice (20 weeks old) were anaesthe-
tized by inhalation of 2% isoﬂurane, 95% oxygen. The depth of anaesthesia
was continually monitored by assessing reﬂexes, respiration, and heart
rate. Osmotic minipumps (Alza Corp, USA) containing AngII (0.4 or
0.8 mg/kg/day for 4 weeks) were implanted subcutaneously. Mice were
recovered and maintained for 4 weeks prior to sacriﬁce.
2.9 Statistical analysis
Data are presented as mean+SEM. Groups were compared using the
Mann–Whitney U test for non-parametric data or Student’s t-test for
parametric data. When comparing multiple groups, data were analysed
by analysis of variance (ANOVA) with the Newman–Keuls post hoc
test for parametric data or the Kruskal–Wallis test with the Dunns
post hoc test for non-parametric data. A value of P , 0.05 was considered
statistically signiﬁcant.
3. Results
3.1 Expression of endothelial-speciﬁc
NADPH oxidases in Nox2-Tg
ApoE
2/2 mice
We ﬁrst aimed to assess whether endothelial expression of human
Nox2 altered the expression of the endogenously expressed
endothelial-speciﬁc NADPH oxidases. There was no difference in ex-
pression of either mouse Nox2 or mouse Nox4 in aortas from
Nox2-Tg ApoE
2/2 mice compared with their ApoE
2/2 littermates.
As expected, expression of the human Nox2 transgene was observed
only in aortas from Nox2-Tg ApoE
2/2 mice (Figure 1A). Western blot
analysis indicated that endothelial-speciﬁc expression of human Nox2
resulted in an increase in total Nox2 protein expression (Figure 1B).
As NADPH oxidase activity in inﬂammatory cells and VSMCs has
been shown to play a role in the progression of atherosclerosis, we
aimed to conﬁrm the cell speciﬁcity of transgenic human Nox2 ex-
pression in Nox2-Tg ApoE
2/2 mice. Importantly, transgenic human
Nox2 was expressed exclusively in endothelial cells from Nox2-Tg
ApoE
2/2 mice and was not detectable in macrophages or VSMCs
from these animals, nor in any cell types from ApoE
2/2 mice, indicat-
ing that expression of the transgene was restricted to the endothelial
cell layer (Figure 2).
3.2 Determination of vascular superoxide
production in Nox2-Tg ApoE
2/2 mice
Previous studies from our group have established that on a wild-type
background, expression of human Nox2 transgene results in an
endothelial-speciﬁc increase in total vascular superoxide production.
To conﬁrm that total vascular superoxide production was still
increased in Nox2-Tg mice on a hyperlipidaemic ApoE
2/2 back-
ground, we measured vascular superoxide production using
2-hydroxyethidium quantiﬁcation and lucigenin-enhanced chemilu-
minescence. In thoracic aortas both methods of measuring NADPH-
stimulated superoxide production (2-hydroxyethidium accumulation
and lucigenin-enhanced chemiluminescence; Figure 3A and B)
showed that superoxide production was signiﬁcantly increased in
the aortas from Nox2-Tg ApoE
2/2 mice compared with their
ApoE
2/2 littermates (ApoE
2/2, 19.9+6.3 vs. Nox2-Tg ApoE
2/2,
47.0+7.0 nmol 2-hydroxyethidium/aorta, P , 0.05). Superoxide
production was inhibited by .90% by diphenylene iodonium
(10 mM; data not shown).
To conﬁrm that the increase in total aortic superoxide production
was due to increased endothelial superoxide production, we assessed
endothelial superoxide production by DHE ﬂuorescence in frozen
aortic root sections. Nox2-Tg ApoE
2/2 mice had signiﬁcantly
greater endothelial superoxide production compared with ApoE
2/2
littermates (9-week-old mice, P , 0.05; Figure 3C). As expected, due
to the expression proﬁle of the transgene, no difference in medial
superoxide production was observed between the two groups
(data not shown).
3.3 Effects of endothelial Nox2
overexpression on endothelial cell
activation and macrophage recruitment
in ApoE
2/2 mice
We next aimed to assess the effect of increased Nox2-derived endo-
thelial superoxide production on endothelial cell activation. VCAM-1
expression is known to be a marker of endothelial cell activation in
ApoE
2/2 mice.
19 VCAM-1 levels were signiﬁcantly increased by
greater than three-fold in aortic roots from 9-week-old Nox2-Tg
ApoE
2/2 mice compared with ApoE
2/2 (1.00+0.178 vs. 0.288+
0.149 mm
2, n ¼ 5, P , 0.05; Figure 4A).
Previous studies have shown that at 9 weeks of age, ApoE
2/2
mice on a chow diet start to show the development of fatty
streaks in the aortic roots driven by monocyte recruitment and re-
tention in the sub-endothelial layer.
20 We next sought to determine
whether the observed increase in VCAM-1 levels observed in
Nox2-Tg ApoE
2/2 mice altered macrophage recruitment to the
aortic root using the macrophage marker CD68. Aortic roots
from 9-week-old Nox2-Tg ApoE
2/2 mice had signiﬁcantly greater
CD68 immunostaining compared with ApoE
2/2 littermates
(0.332+0.073 vs. 0.108+0.018 mm
2, n ¼ 5–8, P , 0.05;
Figure 4B). This ﬁnding was conﬁrmed using a second macrophage
stain (Mac-3) in parafﬁn sections; Mac-3 staining was signiﬁcantly
greater in aortic roots from 9-week-old Nox2-Tg ApoE
2/2 mice
vs. ApoE
2/2 mice (Figure 4C). Macrophage staining was localized
to the luminal surface of the aortic root in fatty streaks; very few
macrophages were observed in the medial cell layer. As expected,
these early fatty streaks stained almost exclusively positive for
macrophages. These ﬁndings indicate that endothelial cell activation
G. Douglas et al. 22and the recruitment of macrophages to fatty streaks are increased
by endothelial-speciﬁc Nox2 overexpression. To eliminate the pos-
sibility of apoptotic changes due to increased levels of endothelial
ROS, we performed TUNEL staining in the aortic roots of 9- and
24-week-old mice. No difference was observed between the two
groups in either endothelial cell or plaque apoptosis (Supplementary
material online, Figure S1).
To ensure that the difference in endothelial cell activation and
macrophage recruitment was not due to any difference in lipid
levels, we assessed lipid levels in the plasma of 9- and 24-week-old
mice. No difference in plasma OxLDL was observed between the
two groups, indicating that increasing endothelial superoxide did
not alter the circulating levels of OxLDL. In addition, there was no
difference in total cholesterol, LDL cholesterol, HDL cholesterol,
or triglycerides between Nox2-Tg ApoE
2/2 and ApoE
2/2 litter-
mates. As observed on a wild-type background, endothelial-speciﬁc
overexpression of Nox2 on a hyperlipademic ApoE
2/2 background
did not alter body weight, basal systolic blood pressure, or pulse
rate at either 9 or 24 weeks of age (Supplementary material online,
Table S1).
3.4 Effects of endothelial Nox2
overexpression on atherosclerotic lesion
formation in ApoE
2/2 mice
To determine how the observed increases in endothelial cell ac-
tivation and macrophage recruitment altered progression of ath-
erosclerosis, aortic root plaque formation was quantiﬁed in
Nox2-Tg ApoE
2/2 mice and ApoE
2/2 littermates at 16 and 24
weeks of age. A signiﬁcant time-dependent increase in aortic
root atherosclerosis was observed from 16 to 24 weeks of age
(Figure 5A, P , 0.05). However, there was no difference in
either atherosclerotic plaque area or in plaque progression
between Nox2-Tg ApoE
2/2 and ApoE
2/2 mice (Figure 5A).
Immunostaining for Mac-3 revealed that the macrophage content
in these advanced lesions was similar between the two groups
(P , 0.05; Figure 5B). In addition, there was no difference in the
composition of the plaque between the two groups, with both
collagen content and plaque smooth muscle cell content similar
between groups as assessed by immunohistochemistry (Supple-
mentary material online, Table S2).
Figure 1 Characterization of NADPH oxidase expression in the Nox2-Tg ApoE
2/2 mouse. (A) mRNA expression of human Nox2, mouse Nox2
and mouse Nox4 in whole aortas from Nox2-Tg ApoE
2/2 and ApoE
2/2 mice. Data were quantiﬁed using the Delta ct method and GAPDH used as
the house-keeping gene. (B) Western blot of global Nox2 in lung homogenates from Nox2-Tg ApoE
2/2 and ApoE
2/2 mice. Data are expressed as
the mean+SEM of n ¼ 3–6 mice per group. *P , 0.05; ND, not detectable.
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altered lipid deposition in the descending aorta, excised aortas were
stained with Oil red O (Figure 5C). As observed in the aortic root,
a time-dependent increase in lipid deposition was observed in both
groups (P , 0.05).
However, there was no difference in lipid deposition in the des-
cending aorta between Nox2-Tg ApoE
2/2 mice and ApoE
2/2 litter-
mates (P . 0.05).
3.5 Effect of angiotensin II on blood
pressure and atherosclerotic plaque
progression
Recent studies have indicated that Nox2 is important for AngII signal-
ling. AngII treatment results in hypertension and accelerated plaque
progression in ApoE
2/2 mice, and hence we sought to determine
whether endothelial-speciﬁc expression of human Nox2 would alter
these responses to AngII. AngII treatment (0.4 or 0.8 mg/kg/day),
delivered for 4 weeks by osmotic minipumps, resulted in a signiﬁcant
increase in systolic blood pressure in both Nox2-Tg ApoE
2/2 mice
and ApoE
2/2 littermates (Nox2-Tg ApoE
2/2 107.6+2.6 vs.
130.2+10.5 mmHg, ApoE
2/2 101.2+3.3 vs. 136.8+9.3 mmHg,
P , 0.001 for both; Supplementary material online, Table S1).
However, there was no difference between Nox2-Tg ApoE
2/2 and
ApoE
2/2 mice in either absolute blood pressure or the rate of
increase in blood pressure after AngII treatment (P ¼ 0.745,
Supplementary material online, Table S1).
To test the effects of AngII on atherosclerosis, we treated mice
with 0.4 or 0.8 mg/kg/day AngII for 4 weeks. There was a dose-
dependent increase in atherosclerosis in both the aortic root and
the thoracic descending aorta (Figure 6, P , 0.05). However, pro-
gression of AngII-induced atherosclerosis was not different
between Nox2-Tg ApoE
2/2 and ApoE
2/2 mice (P , 0.05). In add-
ition there was no difference in the composition of the plaques
Figure 2 Characterization of NADPH oxidase expression in primary vascular cells from the Nox2-Tg ApoE
2/2 mouse. Human Nox2, mouse Nox2
and cell-speciﬁc markers in primary endothelial cells, VSMCs and primary macrophages from Nox2-Tg ApoE
2/2 and ApoE
2/2 mice. Tissue-speciﬁc
markers were PECAM for primary endothelial cells, myosin heavy chain (MHC) III for primary VSMCs, and CD68 for resident macrophages. Data
were quantiﬁed using the Delta ct method, and GAPDH used as the house-keeping gene. Data are expressed as the mean+SEM of n ¼ 3–6
mice per group. *P , 0.05. ND, not detectable.
G. Douglas et al. 24between the two groups, with macrophage, collagen, and smooth
muscle cell content being similar (Supplementary material online,
Table S2).
4. Discussion
In this study, we have investigated the effect of increased endothelial
superoxide production on vascular superoxide production and ath-
erosclerotic plaque progression in ApoE
2/2 mice via targeted
Nox2 overexpression in the endothelium. Our key ﬁndings are that
increased endothelial superoxide production via endothelial cell-
speciﬁc Nox2 overexpression signiﬁcantly increases vascular super-
oxide production. Increased endothelial superoxide production
resulted in increased VCAM-1 levels and enhanced macrophage re-
cruitment at 9 weeks of age. However, this initial increase in macro-
phage recruitment did not result in altered plaque progression at 16
or 24 weeks of age. Nor did overexpression of Nox-2 alter AngII-
driven atherosclerosis.
Vascular disease states, including atherosclerosis, are associated
with a net increase in vascular superoxide, to which NADPH oxidases
in general, and Nox2-containing NADPH oxidase in particular, are im-
portant contributors.
13,21 However, it remains unclear which cellular
sources of vascular superoxide are most important in the pathogen-
esis of atherosclerosis. In this study, we show that an endothelial-
speciﬁc increase in Nox2-derived superoxide production is sufﬁcient
to alter macrophage recruitment and endothelial cell activation, key
factors in the initiation of atherosclerosis in ApoE
2/2 mice. Previous
studies have shown that, in ApoE
2/2 mice, fatty streaks consisting of
lipid-laden macrophages start to appear from 9 weeks of age. Fatty
streaks are initially observed to form a single row in the sub-
endothelial space, later growing in size as the macrophages aggregate
into large groups.
16 This supports the ﬁnding in our study where
macrophage staining was predominantly observed in the sub-
endothelial space as either a single line, or, in more advanced fatty
streaks, in large groups. We hypothesized that the increased macro-
phage recruitment observed in Nox2-Tg ApoE
2/2 mice was driven
by endothelial cell activation. Previous studies have shown that
VCAM-1 plays a major role in the initiation of atherosclerosis.
19 In
addition, Ang II treatment has previously been shown to increase
VCAM-1 expression in endothelial cells.
22 Our data conﬁrm this
ﬁnding, indicating that increased endothelial Nox2-derived superoxide
production results in increased VCAM-1 expression, which is likely to
bring about the observed increase in monocyte recruitment.
This novel ﬁnding is important because Nox2 has been previously
implicated in atherosclerosis in both humans and animal models. Both
Nox2 and Nox4 have been shown to be localized within the plaque of
diseased human coronary arteries,
21 and we have previously demon-
strated that in diseased human coronary arteries mRNA expression of
Nox2 correlated with NADPH oxidase activity.
8 A direct relationship
between Nox2 and atherosclerosis has also been observed in mice.
ApoE
2/2 mice have increased expression of aortic Nox2 compared
with WT mice, and ApoE
2/2 mice lacking Nox2 in all cells have
reduced aortic atherosclerosis compared with ApoE
2/2 mice.
9 Al-
though a role for Nox2 in atherosclerosis has been previous
shown, no study to date has investigated the relative importance of
endothelial superoxide production in atherosclerosis. Our results
Figure 3 Quantiﬁcation of aortic superoxide production in Nox2-Tg ApoE
2/2 and ApoE
2/2 mice. Quantiﬁcation of NADPH-dependent thoracic
aortic superoxide production by (A) 2-hydroxyethidium ﬂuorescence HPLC showed that superoxide production was signiﬁcantly increased in aortas
from 24-week-old Nox2-Tg ApoE
2/2 mice vs. ApoE
2/2 mice (*P , 0.05, n ¼ 9–13). Data are presented as box plots of the tiron-inhibitable fraction
of 2-hydroxyethidium production. (B) Lucigenin-enhanced chemiluminescence showed that superoxide production was signiﬁcantly increased in
aortas from 9 to 18-week-old Nox2-Tg ApoE
2/2 mice vs. ApoE
2/2 mice (*P , 0.05, n ¼ 13–17). (C) 2-Hydroxyethidium ﬂuorescence in frozen
sections of the aortic root from 9-week-old Nox2-Tg ApoE
2/2 mice vs. ApoE
2/2 mice demonstrated that endothelial superoxide production
was signiﬁcantly increased in aortic roots from 9-week-old Nox2-Tg ApoE
2/2 mice vs. ApoE
2/2 mice (*P , 0.05, n ¼ 8–5). Data are presented
as box plots. Area of 2-hydroxyethidium ﬂuorescence in frozen sections was normalized to vessel length.
Endothelial Nox2 and atherosclerosis 25indicate that endothelial Nox2 plays a role in the recruitment of
macrophages to fatty streaks indicating a role for endothelial Nox2
in the initiation of atherosclerosis. However, our ﬁndings also indicate
that once atherosclerotic plaque has been initiated, increased endo-
thelial superoxide has a limited role in plaque progression. This is
interesting as increased vascular superoxide in Nox2-Tg ApoE
2/2
mice was still observed at 24 weeks of age, indicating that the lack
of effect was not due to an overwhelming level of vascular superoxide
production from alternative sources, which might have masked the
elevated superoxide production from the overexpression of Nox2.
In our study, we have shown that an increase in endothelial-speciﬁc
Nox2-derived superoxide production over and above the levels
observed in an ApoE
2/2 mouse does not increase the progression
of atherosclerosis. However, we cannot rule out the possibility of a
threshold effect and that the capacity of endothelial-speciﬁc Nox2-
derived superoxide production to accelerate disease is already satu-
rated. Alternatively, it could be that although Nox2 is up-regulated
in atherosclerosis
9 and we have shown that increased endothelial
Nox2-derived superoxide results in increased macrophage recruit-
ment, Nox2-derived endothelial superoxide may not be critical in
the development of atherosclerosis. Alternative endothelial sources
of ROS such as uncoupled eNOS, lipid peroxides, or an alternative
NADPH oxidase-derived source of ROS such as Nox4 may play a
greater role. The role of Nox4 in the progression of atherosclerosis
has yet to be fully elucidated. Nox4 has a greater relative abundance
in the vasculature compared with Nox2.
4 Unlike Nox2, Nox4 is now
considered to be a hydrogen peroxide, not a superoxide-producing
enzyme,
23 and studies in ApoE
2/2 mice have shown a role for hydro-
gen peroxide in the pathology of atherosclerosis.
24 Future studies
would be required to fully elucidate the role of Nox4 in
atherosclerosis.
Endothelial cells express both Nox2 and Nox4,
3,4 and recent
studies have indicated that Nox2 rather than Nox4 is more important
for AngII-mediated signalling.
25 Indeed, previous studies from our
group have shown that Nox2-Tg mice on a wild-type background
have an increased pressor response to Ang II compared with wild-
type littermates.
15 Hence, endothelial-speciﬁc Nox2-derived super-
oxide may have a greater role in AngII-driven vascular disease
responses. It is well established that AngII treatment results in an
enhanced vascular inﬂammation phenotype, resulting in accelerated
atherosclerosis.
26 In our study, treatment with AngII from 20 to 24
weeks of age signiﬁcantly increased systolic blood pressure and
resulted in a dose-dependent increase in atherosclerosis, demonstrat-
ing that AngII had the expected pathophysiological effects. However,
endothelial-speciﬁc Nox2 overexpression did not alter these athero-
genic responses with no changes in plaque size observed. This could
indicate that Nox2-derived superoxide production in the endothelial
cell layer does not drive accelerated AngII-mediated atherosclerosis.
However, it could be that the relative contribution of endothelial-
speciﬁc AngII-mediated superoxide production in these more
Figure 4 Quantiﬁcation of aortic root VCAM-1 and macrophage levels in Nox2-Tg ApoE
2/2 and ApoE
2/2 mice at 9 weeks of age. (A) Aortic root
VCAM-1 staining (VCAM-1 positive cells stain red) was signiﬁcantly greater in aortic roots from Nox2-Tg ApoE
2/2 mice compared with ApoE
2/2
littermates (P , 0.05, n ¼ 5). (B) Aortic root macrophage content was quantiﬁed by immunohistochemical staining in frozen sections for CD68
(macrophages stained red); Nox2-Tg ApoE
2/2 mice had signiﬁcantly greater macrophage content compared with ApoE
2/2 littermates (P , 0.05,
n ¼ 5–8). (C) Aortic root macrophage content was quantiﬁed by immunohistochemical staining in parafﬁn sections for Mac-3 (macrophages
stained red); Nox2-Tg ApoE
2/2 mice had signiﬁcantly greater macrophage recruitment compared with ApoE
2/2 littermates (P , 0.05, n ¼ 5–8).
For quantiﬁcation of VCAM-1 and CD68 staining, the area of positive staining was normalized to vessel length.
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bution from alternative cell types such as macrophages and VSMCs.
This would conﬁrm our previous ﬁndings that endothelial Nox2
was important in the early stages of atheroslcerotic plaque develop-
ment. In this study, we have used Ang II treatment to accelerate ath-
erosclerosis, as opposed to high-fat feeding. Both Ang II treatment and
high-fat feeding lead to the formation of more advanced lesions;
however, unlike high-fat feeding where lesion growth is stimulated
by increased lipid levels, in the angiotensin II model plaque growth
is stimulated by inﬂammatory cell inﬂux. As we observed a phenotype
in the early inﬂammatory cell recruitment phase, we chose to use the
Ang II model in this study. We elected to use the ApoE
2/2 mouse as
a model of atherosclerosis that develops atherosclerosis on a chow
diet. However, atherosclerosis in the ApoE
2/2 is driven not only
by the lipid environment but also by altered macrophage function
which must also be considered in all studies of this type.
Compensatory changes in the expression of native Nox2 or
another NADPH oxidase subtype might be diminishing the effects
of increased endothelial Nox2-derived superoxide production on ath-
erosclerosis plaque progression. Indeed, previous studies in human
pulmonary endothelial cells have shown that knock-down of Nox2
using siRNA resulted in a compensatory increase in Nox4 mRNA ex-
pression.
27 However, our study found no evidence for a compensa-
tory change in the expression of either native Nox2 or Nox4 in
whole aortas. Furthermore, there was no indication of ‘leaky’ expres-
sion of the transgene, since expression of human Nox2 was restricted
Figure 5 Quantiﬁcation of aortic root and aortic atherosclerosis in Nox2-Tg ApoE
2/2 and ApoE
2/2 mice at 16 and 24 weeks of age. (A) Aortic
root plaque area was quantiﬁed using Masson–Goldner staining of aortic root sections. No difference in plaque area was observed between Nox2-Tg
ApoE
2/2 and ApoE
2/2 mice at 16 or 24 weeks of age (P . 0.05). (B) Aortic root macrophage content was quantiﬁed by immunohistochemical stain-
ing for Mac-3 (macrophages stained red). No difference in macrophage content was observed between Nox2-Tg ApoE
2/2 mice and there ApoE
2/2
littermates (P . 0.05). (C) Aortic atherosclerosis was assessed by en face analysis of Oil red O staining in the aorta of Nox2-Tg ApoE
2/2 mice and
their ApoE
2/2 littermates. No difference in aortic atherosclerosis was observed between Nox2-Tg ApoE
2/2 mice and ApoE
2/2 mice (P . 0.05).
A time-dependent increase in aortic root plaque area, macrophage content, and aortic plaque area was observed in both groups (P , 0.05). Each
point is representative of one animal.
Endothelial Nox2 and atherosclerosis 27to endothelial cells from Nox2-Tg ApoE
2/2 mice and was not
observed in either VSMCs or macrophages from these animals.
However, as demonstrated in our laboratory and by others, Nox4
is more abundantly expressed in the vasculature compared with
Nox2, and thus Nox4-derived superoxide production may play a
more important role in the progression of atherosclerosis.
In conclusion, we have shown that increasing Nox2-derived super-
oxide production speciﬁcally in endothelial cells in the ApoE
2/2
mouse is sufﬁcient to increase vascular superoxide generation, and
results in markedly increased endothelial cell activation and enhanced
macrophage recruitment. However, this increase in recruitment of
macrophages to fatty streaks within the vasculature did not result in
increased plaque progression. These results indicate that Nox-
mediated ROS signalling has important cell-speciﬁc and distinct tem-
poral roles in the initiation and progression of atherosclerosis and
add to our understanding of the speciﬁc role of endothelial-derived
superoxide in these processes.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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